1. Home
  2. TIL vs ASYS Comparison

TIL vs ASYS Comparison

Compare TIL & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • ASYS
  • Stock Information
  • Founded
  • TIL 2018
  • ASYS 1981
  • Country
  • TIL United States
  • ASYS United States
  • Employees
  • TIL N/A
  • ASYS N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • ASYS Industrial Machinery/Components
  • Sector
  • TIL Health Care
  • ASYS Technology
  • Exchange
  • TIL Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • TIL 230.1M
  • ASYS 59.4M
  • IPO Year
  • TIL 2021
  • ASYS N/A
  • Fundamental
  • Price
  • TIL $24.49
  • ASYS $4.81
  • Analyst Decision
  • TIL Buy
  • ASYS
  • Analyst Count
  • TIL 5
  • ASYS 0
  • Target Price
  • TIL $119.00
  • ASYS N/A
  • AVG Volume (30 Days)
  • TIL 310.3K
  • ASYS 41.5K
  • Earning Date
  • TIL 08-12-2025
  • ASYS 08-06-2025
  • Dividend Yield
  • TIL N/A
  • ASYS N/A
  • EPS Growth
  • TIL N/A
  • ASYS N/A
  • EPS
  • TIL N/A
  • ASYS N/A
  • Revenue
  • TIL N/A
  • ASYS $90,826,000.00
  • Revenue This Year
  • TIL N/A
  • ASYS N/A
  • Revenue Next Year
  • TIL N/A
  • ASYS $28.60
  • P/E Ratio
  • TIL N/A
  • ASYS N/A
  • Revenue Growth
  • TIL N/A
  • ASYS N/A
  • 52 Week Low
  • TIL $9.70
  • ASYS $3.20
  • 52 Week High
  • TIL $92.00
  • ASYS $6.96
  • Technical
  • Relative Strength Index (RSI)
  • TIL 47.69
  • ASYS 65.20
  • Support Level
  • TIL $21.80
  • ASYS $4.66
  • Resistance Level
  • TIL $26.91
  • ASYS $4.94
  • Average True Range (ATR)
  • TIL 3.52
  • ASYS 0.25
  • MACD
  • TIL -0.37
  • ASYS 0.04
  • Stochastic Oscillator
  • TIL 35.14
  • ASYS 86.14

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: